MINOXIDIL ASSOCIATED WITH VARIOUS DRUGS AND USE OF OXYTOCIN FOR THE TREATMENT OF FEMALE AND MALE FEMALE DYSFUNCTIONS

摘要

minoxidil associated with various drugs and use of oxytocin to treat female and male sexual dysfunction. The present patent application relates to the claim of development of new pharmaceutical products for treating various female and male sexual dysfunctions. they are drug associations with minoxidil and various forms of presentations. The associated drugs are: (dhea) dehydroepiandrosterone; estradiol; testosterone; phenylalanine; melatonin; bromocriptine; apomorphine; pergolide; prostaglandins - pg 1; sildenafil; tadalafil; vardenafil; yohimbine; bragging; b endorphin; oxytocin alone and in combination with minoxidil, minoxidil alone or in combination. use for clinical treatment of various sexual dysfunctions, such as: alterations of desire, stimulation, orgasmic dysfunctions, dyspareunias and vaginismus; psychogenic impotence, erectile dysfunction, premature ejaculation, delayed ejaculation, hypo-sexuality, hyperssexuality, reduced vaginal lubrication, anor- gmia, women's orgasmic difficulty and vaginismus. Presentations are claimed: cream, gel, solution, vaginal eggs, vaginal creams, ointment, nasal spray, vaginal spray, sublingual spray, liquid, aerosol, sublingual tablets, scheduled release tablets, compressed tablets. oral, sublingual spray, transdermal and intradermal, injectables and v injectables im and injectable im scheduled release. indications for patients with one or more concomitant sexual dysfunction.